
Study group focused on systemic autoimmune disease from the @cientifica_sur #AlmenaraLupusCohort #AlmenaraRACohort #AlmenaraVasculitisCohort
Lima, Peru
Joined January 2026
- Tweets76
- Following293
- Followers27
- Likes92
@VictorioPQ presented his abstract which shows a comparison between MMF and cyclophosphamide in patients with lupus nephritis in the @gladel_latam cohort
@mugartegil presented an abstract on the impact of disease activity on damage accrual in the #Lupusnet network. In total, we were authors/coauthors of 15 abstracts. Also, @VictorioPQ took part in the meeting of the #VCRC and @bhrasco and @mugartegil in the #SLICC meeting #ACR26
GEAS PERU retweeted
Furthermore, I would like to congratulate my fellows and former fellows @VictorioPQ @PaulTejada8 @bhrasco @Asinghrheum for all the amazing work they are doing across various cohorts, including #AlmenaraLupusCohort @gladel_latam and #SLICC cohorts, among others
GEAS PERU retweeted
ACR meetings are always an excellent opportunity to update our knowledge, as well as to network and reconnect with several friends. At this time, I would like to thank my mentor Prof. Chela Alarcón, for all her support over the years!
GEAS PERU retweeted
🌍 CHECK YOUR COUNTRY
How many doctors are available where you live?
📍 Behind these numbers are real consequences:
- Longer waiting times.
- Limited access to medical specialists.
- Overburdened healthcare professionals.
- Delayed diagnoses and preventable deaths.
GEAS PERU retweeted
Are you at the #ACR26? Come and visit our poster on predictors of flares after achieving drug-free remission in the #SLICC cohort by @bhrasco @GEAS_Peru
GEAS PERU retweeted
CONGRESS | #ACR26 | POSTER
Manuel Ugarte-Gil presents findings from a study evaluating the relationship between organ damage and and disease activity in SLE using data from four registries mapped with LupusNet. Patients with ≥3 years of follow-up were stratified by maximum SLEDAI-2K score into mild (≤4; n = 1,666), moderate (>4 to <10; n = 1,068) and severe (≥10; n = 1,000) disease activity.
Overall, the proportion of patients with any damage (SDI ≥1) increased from 39% at registration to 53% at Year 3. Among patients without damage at baseline, new damage developed in 14% of those with mild or moderate disease activity and 18% of those with severe disease activity. These findings highlight the need for ongoing disease monitoring and strategies to prevent damage in SLE.
Follow our live feed for more updates: bit.ly/4iUYXQy
Intended for HCPs. This congress coverage is independently supported through funding from pharmaceutical companies. A full list of our funders can be found on our website. Funders are allowed no influence.
#Lupus #Rheumatology #RheumTwitter #MedEd #MedNews #MedicalCongress @mugartegil @GEAS_Peru
Additionally, @VictorioPQ participated in the #VCRC investigator meeting, he is actively working in some research projects of the #VCRC👏👏#ACR26
Today, two of the members of our group participated in the #SLICC meeting @mugartegil, as a full member of the group, and @bhrasco who is actively working in some research projects of the #SLICC 👏👏
GEAS PERU retweeted
✅ Are you a MEDICAL DOCTOR taking care of #LUPUS? We are trying to map availability and accessibility of #SLE treatments in EVERY COUNTRY OF THE WORLD (check the map of participants) 🌍🌎🌏 and help us by filling-in our #STRIDE study 🙏🔄
LINK to study:lupusresearch.limequery.org/…
GEAS PERU retweeted
Nuevo estudio GLADEL: Identificará los patrones longitudinales de actividad del Lupus y sus determinantes en una cohorte multiétnica latinoamericana.
Objetivo: avanzar hacia una medicina de precisión para el LES en Latinoamérica.
#GLADEL #Lupus #Rheumatology #LupusResearch
🤖 Made with AI
GEAS PERU retweeted
Celebramos nuestro Aniversario Nro. 29
¿Quieres revivir la historia de GLADEL?
Te invitamos a visitar nuestro canal de Youtube y ver el siguiente video: youtube.com/watch?v=C11z-eTZ…
Felicitaciones a todos los investigadores y mentores! Especialmente a los miembros de nuestro grupo @alvarooyarce123 y @bhrasco como investigadores y @mugartegil como mentor👏👏
¡10 proyectos ganadores de nuestro Programa de Investigadores Pro&Pub!
🇨🇴🇵🇪🇦🇷🇲🇽 Investigadores y mentores se unen para abordar los retos del LES y la Nefritis Lúpica. ¡Felicitaciones por su gran aporte a la reumatología!
#GLADEL #Lupus #ProAndPub #Lupus #LES
GEAS PERU retweeted
Felicitaciones a todos los ganadores!!! Especialmente a nuestros residentes @bhrasco y @alvarooyarce123 y nuestra ex-residente @Reumavida!!! Sigan así!! 👏👏👏
¡Tenemos a los 10 ganadores de Pro&Pub!
De 19 proyectos presentados, el Comité Científico seleccionó a los mejores por su rigor e innovación. ¡Felicitaciones a los ganadores por este gran logro! 👇
#ProAndPub #Innovación #Investigación #GLADEL #LES #Lupus #Ganadores
Felicitaciones a los ganadores!! Especialmente a @alvarooyarce123 y @bhrasco que son miembros de nuestro grupo!!👏👏👏 Y un reconocimiento a @gladel_latam por esta iniciativa que permitirá tener más y mejores investigadores en #LatAm @PanlarLeague @PanlarJ
¡Tenemos a los 10 ganadores de Pro&Pub!
De 19 proyectos presentados, el Comité Científico seleccionó a los mejores por su rigor e innovación. ¡Felicitaciones a los ganadores por este gran logro! 👇
#ProAndPub #Innovación #Investigación #GLADEL #LES #Lupus #Ganadores
Replying to @physicianswkly
@physicianswkly highlights the relevance of our study on the impact of #frailty on the #mortality risk in #SLE patients from the #AlmenaraLupusCohort. #Frailty is a potentially modifiable factor, we need to establish strategies to improve it! physiciansweekly.com/post/fr…











































